Influence of severity of illness on the effects of eritoran and on other therapies for severe sepsis.

Trial Profile

Influence of severity of illness on the effects of eritoran and on other therapies for severe sepsis.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2011

At a glance

  • Drugs Eritoran (Primary)
  • Indications Sepsis
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top